First Manhattan
CNCE

First Manhattan’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

First Manhattan’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-453,091
Closed -$5.47M – 1469
2019
Q1 		$5.47M Sell
453,091
-596,443
-57% -$8.79M 0.03% 226
2018
Q4 		$13.2M Buy
1,049,534
+484,739
+86% +$6.69M 0.08% 137
2018
Q3 		$8.38M Buy
+564,795
New +$8.89M 0.04% 209
2018
Q1 		– Sell
-17,900
Closed -$463K – 1488
2017
Q4 		$463K Sell
17,900
-51,000
-74% -$1.03M ﹤0.01% 561
2017
Q3 		$1.02M Buy
+68,900
New +$1,000K 0.01% 438

Other funds holding CNCE

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return